Hierarchical Regulation of Wound Healing by NOD-Like Receptors in Cardiovascular Disease

Antioxidants and Redox Signaling

Volumn 22, Issue 13, 2015, Pages 1176-1187

  Bracey, Nathan A ^a   Duff, Henry J ^b   Muruve, Daniel A ^a  

^a UNIVERSITY OF CALGARY   (Canada)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

INFLAMMASOME; INTERLEUKIN 1BETA; NUCLEOTIDE BINDING OLIGOMERIZATION DOMAIN LIKE RECEPTOR; PATTERN RECOGNITION RECEPTOR; CARRIER PROTEIN; NLRP3 PROTEIN, HUMAN;

CARDIOVASCULAR DISEASE; CELL POPULATION; CELL STRUCTURE; CHRONIC DISEASE; CYTOKINE PRODUCTION; HEART FUNCTION; HEART INJURY; HEART MUSCLE FIBROSIS; HUMAN; IMMUNOCOMPETENT CELL; MITOCHONDRION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VASCULAR REMODELING; WOUND HEALING; ANIMAL; CHEMISTRY; FIBROSIS; GENE EXPRESSION; GENETIC POLYMORPHISM; HOMEOSTASIS; IMMUNOLOGY; METABOLISM; PATHOLOGY;

ANIMALS; CARDIOVASCULAR DISEASES; CARRIER PROTEINS; FIBROSIS; GENE EXPRESSION; HOMEOSTASIS; HUMANS; INFLAMMASOMES; MITOCHONDRIA; POLYMORPHISM, GENETIC; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 84934753504     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.6125     Document Type: Review

References (88)

1. Aganna E, Martinon F, Hawkins PN, Ross JB, Swan DC, Booth DR, Lachmann HJ, Bybee A, Gaudet R, Woo P, Feighery C, Cotter FE, Thome M, Hitman GA, Tschopp J, and McDermott MF. Association of mutations in the NALP3/CIAS1/PYPAF1 gene with a broad phenotype including recurrent fever, cold sensitivity, sensorineural deafness, and AA amyloidosis. Arthritis Rheum 46: 2445-2452, 2002.
2. Agostini L, Martinon F, Burns K, McDermott M, Hawkins P, and Tschopp J. NALP3 forms an IL-1β processing inflammasome with increased activity in muckle-wells autoinflammatory disorder. Immunity 20: 319-325, 2004.
3. Akira S and Takeda K. Toll-like receptor signalling. Nat Rev Immunol 4: 499-511, 2004.
4. Andrei C, Dazzi C, Lotti L, Torrisi MR, Chimini G, and Rubartelli A. The secretory route of the leaderless protein interleukin 1b involves exocytosis of endolysosome-related vesicles. Mol Biol Cell 10: 1463-1475, 1999.
5. Aravind L, Dixit VM, and Koonin EV. The domains of death: evolution of the apoptosis machinery. Trends Biochem Sci 24: 47-53, 1999.
6. Arnoult D, Soares F, Tattoli I, Castanier C, Philpott DJ, and Girardin SE. An N-terminal addressing sequence targets NLRX1 to the mitochondrial matrix. J Cell Sci 122: 3161-3168, 2009.
7. Artlett CM, Sassi-Gaha S, Rieger JL, Boesteanu AC, Feghali-Bostwick CA, and Katsikis PD. The inflammasome activating caspase 1 mediates fibrosis and myofibroblast differentiation in systemic sclerosis. Arthritis Rheum 63: 3563-3574, 2011.
8. Bird S, Zou J, Wang T, Munday B, Cunningham C, and Secombes CJ. Evolution of interleukin-1β. Cytokine Growth Factor Rev 13: 483-502, 2002.
9. Boatright KM, Renatus M, Scott FL, Sperandio S, Shin H, Pedersen IM, Ricci JE, Edris WA, Sutherlin DP, Green DR, and Salvesen GS. A unified model for apical caspase activation. Mol Cell 11: 529-541, 2003.
10. Bracey N, Gershkovich B, Chun J, Vilaysane A, Meijndert C, Wright J, Fedak P, Beck P, Muruve D, and Duff H. Mitochondrial NLRP3 induces reactive oxygen species to promote smad signalling and fibrosis independent from the inflammasome. J Biol Chem 289: 19571-19584, 2014.
11. Bracey NA, Beck PL, Muruve DA, Hirota SA, Guo J, Jabagi H, Wright JR, Macdonald JA, Lees-Miller JP, Roach D, Semeniuk LM, and Duff HJ. The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through IL-1β. Exp Physiol 98: 462-472, 2013.
12. Dehghan A, Yang Q, Peters A, Basu S, Bis JC, Rudnicka AR, Kavousi M, Chen MH, Baumert J, Lowe GD, McKnight B, Tang W, de Maat M, Larson MG, Eyhermendy S, McArdle WL, Lumley T, Pankow JS, Hofman A, Massaro JM, Rivadeneira F, Kolz M, Taylor KD, van Duijn CM, Kathiresan S, Illig T, Aulchenko YS, Volcik KA, Johnson AD, Uitterlinden AG, Tofler GH, Gieger C; Wellcome Trust Case Control Consortium, Psaty BM, Couper DJ, Boerwinkle E, Koenig W, O'Donnell CJ, Witteman JC, Strachan DP, Smith NL, and Folsom AR. Association of novel genetic loci with circulating fibrinogen levels: a genome-wide association study in six population-based cohorts. Circ Cardiovasc Genet 2: 125-133, 2009.
13. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood 87: 2095-2147, 1996.
14. Dinarello C. Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519-550, 2009.
15. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nuñez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, and Latz E. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464: 1357-1361, 2010.
16. Eliezer D. Folding pyrin into the family. Structure 11: 1190-1191, 2003.
17. Enkhbayar P, Kamiya M, Osaki M, Matsumoto T, and Matsushima N. Structural principles of leucine-rich repeat (LRR) proteins. Proteins 54: 394-403, 2004.
18. Ertl G and Frantz S. Healing after myocardial infarction. Cardiovasc Res 66: 22-32, 2005.
19. Fairbrother WJ, Gordon NC, Humke EW, O'Rourke KM, Starovasnik MA, Yin JP, and Dixit VM. The PYRIN domain: a member of the death domain-fold superfamily. Protein Sci 10: 1911-1918, 2001.
20. Frantz S, Ducharme A, Sawyer D, Rohde LE, Kobzik L, Fukazawa R, Tracey D, Allen H, Lee RT, and Kelly RA. Targeted deletion of caspase-1 reduces early mortality and left ventricular dilatation following myocardial infarction. J Mol Cell Cardiol 35: 685-694, 2003.
21. Girardin SE, Boneca IG, Carneiro LA, Antignac A, Jéhanno M, Viala J, Tedin K, Taha MK, Labigne A, Zähringer U, Coyle AJ, DiStefano PS, Bertin J, Sansonetti PJ, and Philpott DJ. Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan. Science 300: 1584-1587, 2003.
22. Gonzalez A, Lopez B, and Diez J. Myocardial fibrosis in arterial hypertension. Eur Heart J. 4: 18-22, 2002.
23. Henao-Mejia J, Elinav E, Jin C, Hao L, Mehal WZ, Strowig T, Thaiss CA, Kau AL, Eisenbarth SC, Jurczak MJ, Camporez JP, Shulman GI, Gordon JI, Hoffman HM, and Flavell RA. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature 482: 179-185, 2012.
24. Hengartner M. The biochemistry of apoptosis. Nature 407: 770-776, 2000.
25. Hermansson C, Lundqvist A, Wasslavik C, Palmqvist L, Jeppsson A, and Hultén LM. Reduced expression of NLRP3 and MEFV in human ischemic heart tissue. Biochem Biophys Res Commun 430: 425-428, 2013.
26. Hoffman HM, Mueller JL, Broide DH, Wanderer AA, and Kolodner RD. Mutation of a new gene encoding a putative pyrin-like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nat Genet 29: 301-305, 2001.
27. Hofmann K, Bucher P, and Tschopp J. The CARD domain: a new apoptotic signalling motif. Trends Biochem Sci 22: 155-156, 1997.
28. Hornung V, Bauernfeind F, Halle A, Samstad EO, Kono H, Rock KL, Fitzgerald KA, and Latz E. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. Nat Immunol 9: 847-856, 2008.
29. Istomin A and Godzik A. Understanding diversity of human innate immunity receptors: analysis of surface features of leucine-rich repeat domains in NLRs and TLRs. BMC Immunol 10: 48, 2009.
30. Jessup M and Brozena S. Heart failure. N Engl J Med 348: 2007-2018, 2003.
31. Jong WM and Zuurbier CJ. A role for NLRP3 inflammasome in acute myocardial ischaemia-reperfusion injury? Cardiovasc Res 99: 226, 2013.
32. Kawaguchi M, Takahashi M, Hata T, Kashima Y, Usui F, Morimoto H, Izawa A, Takahashi Y, Masumoto J, Koyama J, Hongo M, Noda T, Nakayama J, Sagara J, Taniguchi S, and Ikeda U. Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia/reperfusion injury. Circulation 123: 594-604, 2011.
33. Kobe B and Kajava A. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 11: 725-732, 2001.
34. Kominato Y, Galson D, Waterman WR, Webb AC, and Auron PE. Monocyte expression of the human prointerleukin 1 beta gene (IL1B) is dependent on promoter sequences which bind the hematopoietic transcription factor Spi-1/PU.1. Mol Cell Biol 15: 58-68, 1995.
35. Lamkanfi M and Dixit V. Inflammasomes: guardians of cytosolic sanctity. Immunol Rev 227: 95-105, 2009.
36. Lamkanfi M, Mueller JL, Vitari AC, Misaghi S, Fedorova A, Deshayes K, Lee WP, Hoffman HM, and Dixit VM. Glyburide inhibits the Cryopyrin/Nalp3 inflammasome. J Cell Biol 187: 61-70, 2009.
37. Lech M, Avila-Ferrufino A, Skuginna V, Susanti HE, and Anders HJ. Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. Int Immunol 22: 717-728, 2010.
38. Lee S, Kwon K, Kim S, and Rhee S. Reversible inactivation of protein-tyrosine phosphatase 1B in A431 cells stimulated with epidermal growth factor. J Biol Chem 273: 15366-15372, 1998.
39. Leipe DD, Koonin EV, and Aravind L. STAND, a class of P-Loop NTPases including animal and plant regulators of programmed cell death: multiple, complex domain architectures, unusual phyletic patterns, and evolution by horizontal gene transfer. J Mol Biol 343: 1-28, 2004.
40. Lonnemann G, Engler-Blum G, Müller GA, Koch KM, and Dinarello CA. Cytokines in human renal interstitial fibrosis. II. Intrinsic interleukin (IL)-1 synthesis and IL-1-dependent production of IL-6 and IL-8 by cultured kidney fibroblasts. Kidney Int 47: 845-854, 1995.
41. Luheshi NM, Giles JA, Lopez-Castejon G, and Brough D. Sphingosine regulates the NLRP3-inflammasome and IL-1β release from macrophages. Eur J Immunol 42: 716-725, 2012.
42. Luo B, Wang F, Li B, Dong Z, Liu X, Zhang C, and An F. Association of nucleotide-binding oligomerization domainlike receptor 3 inflammasome and adverse clinical outcomes in patients with idiopathic dilated cardiomyopathy. Clin Chem Lab Med 51: 1521-1528, 2013.
43. Marchetti C, Chojnacki J, Toldo S, Mezzaroma E, Tranchida N, Rose SW, Federici M, Van Tassell BW, Zhang S, and Abbate A. A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury following ischemia-reperfusion in the mouse. J Cardiovasc Pharmacol 63: 316-322, 2014.
44. Mariathasan S, Weiss DS, Newton K, McBride J, O'Rourke K, Roose-Girma M, Lee WP, Weinrauch Y, Monack DM, and Dixit VM. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature 440: 228-232, 2006.
45. Maron BJ, Ferrans VJ, and Roberts WC. Ultrastructural features of degenerated cardiac muscle cells in patients with cardiac hypertrophy. Am J Pathol 79: 387-434, 1975.
46. Martinon F and Tschopp J. NLRs join TLRs as innate sensors of pathogens. Trends Immunol 26: 447-454, 2005.
47. Martinon F and Tschopp J. Inflammatory caspases and inflammasomes: master switches of inflammation. Cell Death Differ 14: 10-22, 2007.
48. Martinon F, Burns K, and Tschopp J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and processing of proIL-beta. Mol Cell 10: 417-426, 2002.
49. Martinon F, Hofmann K, and Tschopp J. The pyrin domain: a possible member of the death domain-fold family implicated in apoptosis and inflammation. Curr Biol 11: R118-R120, 2001.
50. Martinon F, Pétrilli V, Mayor A, Tardivel A, and Tschopp J. Gout-associated uric acid crystals activate the NALP3 inflammasome. Nature 440: 237-241, 2006.
51. Matzinger P. Tolerance, danger and the extended family. Annu Rev Immunol 12: 991-1045, 1994.
52. Matzinger P. The danger model: a renewed sense of self. Science 12: 301-305, 2002.
53. Medzhitov R and Janeway CA Jr. Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9: 4-9, 1997.
54. Medzhitov R, Schneider D, and Soares M. Disease tolerance as a defense strategy. Science 335: 936-941, 2012.
55. Mezzaroma E, Toldo S, Farkas D, Seropian IM, Van Tassell BW, Salloum FN, Kannan HR, Menna AC, Voelkel NF, and Abbate A. The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse. Proc Natl Acad Sci U S A 108: 19725-19730, 2011.
56. Moore CB, Bergstralh DT, Duncan JA, Lei Y, Morrison TE, Zimmermann AG, Accavitti-Loper MA, Madden VJ, Sun L, Ye Z, Lich JD, Heise MT, Chen Z, and Ting JP. NLRX1 is a regulator of mitochondrial antiviral immunity. Nature 451: 573-577, 2008.
57. Muruve DA, Pétrilli V, Zaiss AK, White LR, Clark SA, Ross PJ, Parks RJ, and Tschopp J. The inflammasome recognizes cytosolic microbial and host DNA and triggers an innate immune response. Nature 452: 103-107, 2008.
58. Nicholson D. Caspase structure, proteolytic substrates, and function during apoptotic cell death. Cell Death Differ 6: 1028-1042, 1999.
59. Park S, Juliana C, Hong S, Datta P, Hwang I, Fernandes-Alnemri T, Yu JW, and Alnemri ES. The mitochondrial antiviral protein MAVS associates with NLRP3 and regulates its inflammasome activity. J Immunol 191: 4358-4366, 2013.
60. Perregaux D and Gabel CA. Interleukin-lb maturation and release in response to ATP and nigericin. J Biol Chem 269: 15195-15203, 1994.
61. Proell M, Riedl SJ, Fritz JH, Rojas AM, and Schwarzenbacher R. The Nod-like receptor (NLR) family: a tale of similarities and differences. PLoS One 3: 1-11, 2008.
62. Robinson K, Stewart C, Pye, Q, Floyd R, and Hensley K. Basal protein phosphorylation is decreased and phosphatase activity increased by an antioxidant and a free radical trap in primary rat glia. Arch Biochem Biophys 365: 211-215, 1999.
63. Rosca M and Hoppel C. Mitochondria in heart failure. Cardiovasc Res 88: 40-50, 2010.
64. Sandanger Ø, Ranheim T, Vinge LE, Bliksøen M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, and Yndestad A. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 99: 164-174, 2013.
65. Schatz G. The protein import system of mitochondria. J Biol Chem 271: 31763-31766, 1996.
66. Scholl T, Mahanta SK, and Strominger JL. Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. Proc Natl Acad Sci U S A 94: 6330-6334, 1997.
67. Schroder K, Zhou R, and Tschopp J. The NLRP3 inflammasome: a sensor for metabolic danger? Science 327: 296-300, 2010.
68. Schubert WD, Urbanke C, Ziehm T, Beier V, Machner MP, Domann E, Wehland J, Chakraborty T, and Heinz DW. Structure of internalin, a major invasion protein of Listeria monocytogenes, in complex with its human receptor Ecadherin. Cell 111: 825-836, 2002.
69. Shigeoka AA, Mueller JL, Kambo A, Mathison JC, King AJ, Hall WF, Correia Jda S, Ulevitch RJ, Hoffman HM, and McKay DB. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol 185: 6277-6285, 2010.
70. Sokolavoska A, Becker CE, Eddie Ip WK, Rathinam VAK, Brudner M, Paquette N, Tanne A, Vanaja SK, Moore KJ, Fitzgerald KA, Lacy-Hulbert A, and Stuart LM. Activation of caspase-1 by the NLRP3 inflammasome regulates the NADPH oxidase NOX2 to control phagosome function. Nat Immunol 14: 543-553, 2013.
71. Subramanian N, Natarajan K, Clatworthy MR, Wang Z, and Germain RN. The adaptor MAVS promotes NLRP3 mitochondrial localization and inflammasome activation. Cell 153: 348-361, 2013.
72. Tattoli I, Carneiro LA, Jéhanno M, Magalhaes JG, Shu Y, Philpott DJ, Arnoult D, and Girardin SE. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep 9: 293-300, 2008.
73. Ting JP, Lovering RC, Alnemri ES, Bertin J, Boss JM, Davis BK, Flavell RA, Girardin SE, Godzik A, Harton JA, Hoffman HM, Hugot JP, Inohara N, Mackenzie A, Maltais LJ, Nunez G, Ogura Y, Otten LA, Philpott D, Reed JC, Reith W, Schreiber S, Steimle V, and Ward PA. The NLR gene family: a standard nomenclature. Immunity 28: 285-287, 2008.
74. Tschopp J, Martinon F, and Burns K. NALPs: a novel protein family involved in inflammation. Nat Rev Mol Cell Biol 4: 95-104, 2003.
75. Vandanmagsar B, Youm YH, Ravussin A, Galgani JE, Stadler K, Mynatt RL, Ravussin E, Stephens JM, and Dixit VD. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat Med 17: 179-188, 2011.
76. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L, and Narula J. Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7: 30-37, 2010.
77. Varghese GP, Fransén K, Hurtig-Wennlöf A, Bengtsson T, Jansson JH, and Sirsjö A. Q705K variant in NLRP3 gene confers protection against myocardial infarction in female individuals. Biomed Rep 1: 879-882, 2013.
78. Vilaysane A, Chun J, Seamone ME, Wang W, Chin R, Hirota S, Li Y, Clark SA, Tschopp J, Trpkov K, Hemmelgarn BR, Beck PL, and Muruve DA. The NLRP3 inflammasome promotes renal inflammation and contributes to CKD. J Am Soc Nephrol 21: 1732-1744, 2010.
79. Walker J, Saraste M, Runswick M, and Gay N. Distantly related sequences in the a and b subunits of ATP synthase, myosin and other ATP-requiring enzymes and a common nucleotide binding fold. EMBO J 945-951, 1982.
80. Wang W, Wang X, Chun J, Vilaysane A, Clark S, French G, Bracey NA, Trpkov K, Bonni S, Duff HJ, Beck PL, and Muruve DA. Inflammasome-independent NLRP3 augments TGF-β signaling in kidney epithelium. J Immunol 190: 1239-1249, 2013.
81. Xiao H, Lu M, Lin TY, Chen Z, Chen G, Wang WC, Marin T, Shentu TP, Wen L, Gongol B, Sun W, Liang X, Chen J, Huang HD, Pedra JH, Johnson DA, and Shyy JY. Sterol regulatory element binding protein 2 activation of NLRP3 inflammasome in endothelium mediates hemodynamic-induced atherosclerosis susceptibility. Circulation 128: 632-642, 2013.
82. Yin Y, Yan Y, Jiang X, Mai J, Chen NC, Wang H, and Yang XF. Inflammasomes are differentially expressed in cardiovascular and other tissues. Int J Immunopathol Pharmacol 22: 311-322, 2009.
83. Zak R, Rabinowitz M, Rajamanickam C, Merten S, and Kwiatkowska-Patzer B. Mitochondrial proliferation in cardiac hypertrophy. Basic Res Cardiol 75: 171-178, 1980.
84. Zhao Y, Yang J, Shi J, Gong YN, Lu Q, Xu H, Liu L, and Shao F. The NLRC4 inflammasome receptors for bacterial flagellin and type III secretion apparatus. Nature 477: 596-600, 2011.
85. Zheng N, Schulman BA, Song L, Miller JJ, Jeffrey PD, Wang P, Chu C, Koepp DM, Elledge SJ, Pagano M, Conaway RC, Conaway JW, Harper JW, and Pavletich NP. Structure of the Cul1-Rbx1-Skp1-F boxSkp2 SCF ubiquitin ligase complex. Nature 416: 703-709, 2002.
86. Zhou R, Tardivel A, Thorens B, Choi I, and Tschopp J. Thioredoxin-interacting protein links oxidative stress to inflammasome activation. Nat Immunol 11: 136-140, 2010.
87. Zhou R, Yazdi AS, Menu P, and Tschopp J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469: 221-225, 2011.
88. Zuurbier CJ, Jong WM, Eerbeek O, Koeman A, Pulskens WP, Butter LM, Leemans JC, and Hollmann MW. Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6/STAT3 signaling. PLoS One 7: e40643, 2012.